Co-Occurring Methylenetetrahydrofolate Reductase (
MTHFR
Rett Syndrome
clinical severity
pharmacogenomics
remethylation
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
21 Jun 2024
21 Jun 2024
Historique:
received:
17
05
2024
revised:
18
06
2024
accepted:
19
06
2024
medline:
27
7
2024
pubmed:
27
7
2024
entrez:
27
7
2024
Statut:
epublish
Résumé
Remethylation disorders such as 5,10-methylenetetrahydrofolate reductase ( Using pharmacogenomic (PGx) testing, the The clinical severity symptom distribution varied between the homozygous and heterozygous Our findings show that in those with a pathogenic RTT genetic variant, co-occurring homozygotic
Identifiants
pubmed: 39061365
pii: brainsci14070624
doi: 10.3390/brainsci14070624
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Reverse Rett
ID : RE16403